Cat. No. | Product name | CAS No. |
DC11647 |
JNJ-2408068
Featured
JNJ 2408068 is a potent RSV (respiratory syncytial virus) inhibitor. JNJ2408068 significantly inhibits replication of RSV A and B subtypes in the lungs of cotton rats without any evidence of toxicity. The minimum protective dose of JNJ 2408068 appears to be approximately 0.39 mg/kg[1]. |
317846-22-3 |
DC11731 |
Ruzasvir
A potent, pan-genotype HCV NS5A inhibitor with replicon EC90 of 0.003, 0.016, 0.067, 0.036, 0.007, and 0.007 nM for GT1a, GT1a L31V, GT1a Y93H, GT2b, GT3a, and Gt4a, respectively.. |
1613081-64-3 |
DC11849 |
DSM421
A potent, selective P. falciparum dihydroorotate dehydrogenase (PfDHODH) with IC50 of 53 nM. |
1281861-06-0 |
DC11871 |
MMV019313
Featured
MMV019313 (MMV 019313, MMV-019313) is a potent, specific malaria bifunctional farnesyl/geranylgeranyl diphosphate synthase (FPPS/GGPPS) inhibitor with IC50 of 330 nM; shows no activity against human FPPS or GGPPS (>200 uM); exhibits distinct modes of inhibition compared with bisphosphonates, inhibits P. falciparum growth with EC50 of 268 nM, overexpression and an S228T variant of PfFPPS/GGPPS confer resistance to MMV 019313. |
902630-14-2 |
DC11737 |
GNF-6702
A selective, non-competitive inhibitor of the kinetoplastid proteasome, inhibits the chymotrypsin-like activity of the T. cruzi proteasome with IC50 of 35 nM. |
1799329-72-8 |
DC11752 |
iKIX1
A small-molecule inhibitor of the interaction of the C. glabrata Pdr1 activation domain with the C. glabrata Gal11A KIX domain with Ki of 18 uM. |
656222-54-7 |
DC11774 |
YM-53403
A specific anti-respiratory syncytial virus (RSV) agent with EC50 of 0.2 uM in plaque reduction assays. |
851331-05-0 |
DC10797 |
AB-423
Featured
AB-423 is the first-generation Hepatitis B Virus Capsid Assembly inhibitor, which was generally safe and well tolerated in Phase 1 healthy volunteer studies. |
1572510-80-5 |
DC9029 |
Abacavir
Abacavir is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS. |
136470-78-5 |
DCAPI1273 |
Acyclovir (Aciclovir)
Acyclovir (Aciclovir) |
59277-89-3 |
DC10513 |
AFN-1252(Debio 1452)
Featured
AFN-1252(Debio 1452) is a potent inhibitor of enoyl-acyl carrier protein reductase (FabI), inhibited all clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis at concentrations of ≤0.12 μg/ml. |
620175-39-5 |
DC10303 |
Allopurinol riboside
Allopurinol riboside, a metabolite of allopurinol, shows potent activities against parasites. |
16220-07-8 |
DC10621 |
Amenamevir
Featured
Amenamevir, also known as ASP2151, is a herpes virus helicase-primase inhibitor. |
841301-32-4 |
DC7058 |
Amprenavir
Amprenavir (Agenerase) is a HIV protease inhibitor(Ki=0.6 nM) used to treat HIV infection. |
161814-49-9 |
DC11738 |
SCYX-7158
An orally-active, CNS permeable benzoxaborole antiprotozoal agent. |
1266084-51-8 |
DC7061 |
AN-2690(Tavaborole)
AN-2690(Tavaborole), an antifungal agent with activity against Trichophyton species, in a topical solution formulation, for the potential treatment of onychomycosis. |
174671-46-6 |
DC9827 |
AN3365(Epetraborole)
Featured
AN3365 is a first-in-class antibiotic that demonstrates potent activity across a wide spectrum of Gram-negative bacteria, including those resistant to many other antibiotics. |
1234563-16-6 |
DC10168 |
Anle138b
Featured
Anle138b is a novel oligomer modulator. |
882697-00-9 |
DC11088 |
Fosmanogepix
antifungal. |
2091769-17-2 |
DC11407 |
Asapiprant(BGE-175)
Featured
Asapiprant (BGE-175) is a potent and specific antagonist of human PGD2/PTGDR signaling with Ki of 0.44 nM. BGE-175 is currently in a Phase 2 clinical trial to test whether it can prevent disease progression and mortality in older patients hospitalized wit |
932372-01-5 |
DC3150 |
Atazanavir
Featured
Atazanavir is a HIV protease inhibitor with Ki of 2.66 nM. |
198904-31-3 |
DC9480 |
Atazanavir (sulfate)
Atazanavir sulfate is a sulfate salt form of atazanavir that is an highly potent HIV-1 protease inhibitor. |
229975-97-7 |